Faculty Collaboration Database

An axillary recurrence of breast cancer following a negative sentinel lymph node biopsy. Breast J 2003;9(3):234-6

Date

05/20/2003

Pubmed ID

12752634

DOI

10.1046/j.1524-4741.2003.09321.x

Scopus ID

2-s2.0-0038102420 (requires institutional sign-in at Scopus site)   9 Citations

Abstract

In many parts of the United States, lymphatic mapping and sentinel lymph node biopsy has almost replaced axillary lymph node dissection (ALND) as the axillary staging procedure of choice for small, clinically node-negative breast cancers. However, the long-term outcome of patients undergoing a sentinel lymph node biopsy as the only axillary procedure in patients with tumor-free sentinel nodes remains to be determined. We present the first reported case of axillary recurrence in a patient with breast cancer following a tumor-negative sentinel lymph node biopsy. Whether sentinel lymph node biopsy can replace ALND in the management of patients with early breast cancer remains to be answered.

Author List

Yen TW, Mann GN, Lawton TJ, Livingston RB, Anderson BO

Author

Tina W F Yen MD, MS Professor in the Surgery department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Axilla
Breast Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Combined Modality Therapy
Female
Humans
Middle Aged
Neoplasm Recurrence, Local
Sentinel Lymph Node Biopsy